BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 24241494)

  • 1. Circulating serum microRNAs as novel diagnostic and prognostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance.
    Kubiczkova L; Kryukov F; Slaby O; Dementyeva E; Jarkovsky J; Nekvindova J; Radova L; Greslikova H; Kuglik P; Vetesnikova E; Pour L; Adam Z; Sevcikova S; Hajek R
    Haematologica; 2014 Mar; 99(3):511-8. PubMed ID: 24241494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating miRNAs as diagnostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance.
    Li J; Zhang M; Wang C
    J Clin Lab Anal; 2020 Jun; 34(6):e23233. PubMed ID: 32039495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of circulating microRNAs as diagnostic biomarkers for use in multiple myeloma.
    Jones CI; Zabolotskaya MV; King AJ; Stewart HJ; Horne GA; Chevassut TJ; Newbury SF
    Br J Cancer; 2012 Dec; 107(12):1987-96. PubMed ID: 23169280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of microRNA-221/222 in patients with monoclonal gammopathy of undetermined significance and multiple myeloma].
    Yang S; Wang W; Jin H; Zhong Y; Xie X
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 May; 45(4):371-378. PubMed ID: 27868410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum exosomal microRNAs as novel biomarkers for multiple myeloma.
    Zhang ZY; Li YC; Geng CY; Zhou HX; Gao W; Chen WM
    Hematol Oncol; 2019 Oct; 37(4):409-417. PubMed ID: 31102419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA expression in multiple myeloma is associated with genetic subtype, isotype and survival.
    Chi J; Ballabio E; Chen XH; Kušec R; Taylor S; Hay D; Tramonti D; Saunders NJ; Littlewood T; Pezzella F; Boultwood J; Wainscoat JS; Hatton CS; Lawrie CH
    Biol Direct; 2011 May; 6():23. PubMed ID: 21592325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis.
    Zhan F; Barlogie B; Arzoumanian V; Huang Y; Williams DR; Hollmig K; Pineda-Roman M; Tricot G; van Rhee F; Zangari M; Dhodapkar M; Shaughnessy JD
    Blood; 2007 Feb; 109(4):1692-700. PubMed ID: 17023574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of Dicer is more frequent in monoclonal gammopathies of undetermined significance than in multiple myeloma patients and is associated with longer survival in symptomatic myeloma patients.
    Sarasquete ME; Gutiérrez NC; Misiewicz-Krzeminska I; Paiva B; Chillón MC; Alcoceba M; García-Sanz R; Hernández JM; González M; San-Miguel JF
    Haematologica; 2011 Mar; 96(3):468-71. PubMed ID: 21160068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary monoclonal gammopathy of undetermined significance after allogeneic stem cell transplantation in multiple myeloma.
    Schmitz MF; Otten HG; Franssen LE; van Dorp S; Strooisma T; Lokhorst HM; van de Donk NW
    Haematologica; 2014 Dec; 99(12):1846-53. PubMed ID: 25193963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant Levels of miRNAs in Bone Marrow Microenvironment and Peripheral Blood of Myeloma Patients and Disease Progression.
    Wang W; Corrigan-Cummins M; Barber EA; Saleh LM; Zingone A; Ghafoor A; Costello R; Zhang Y; Kurlander RJ; Korde N; Roccaro AM; Ghobrial IM; Landgren O; Calvo KR
    J Mol Diagn; 2015 Nov; 17(6):669-78. PubMed ID: 26433312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-15a/16-1 cluster located at chromosome 13q14 is down-regulated but displays different expression pattern and prognostic significance in multiple myeloma.
    Li F; Xu Y; Deng S; Li Z; Zou D; Yi S; Sui W; Hao M; Qiu L
    Oncotarget; 2015 Nov; 6(35):38270-82. PubMed ID: 26516702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and biologic markers of progression in monoclonal gammopathy of undetermined significance to multiple myeloma.
    Mailankody S; Mena E; Yuan CM; Balakumaran A; Kuehl WM; Landgren O
    Leuk Lymphoma; 2010 Dec; 51(12):2159-70. PubMed ID: 20958231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The spectrum of somatic mutations in monoclonal gammopathy of undetermined significance indicates a less complex genomic landscape than that in multiple myeloma.
    Mikulasova A; Wardell CP; Murison A; Boyle EM; Jackson GH; Smetana J; Kufova Z; Pour L; Sandecka V; Almasi M; Vsianska P; Gregora E; Kuglik P; Hajek R; Davies FE; Morgan GJ; Walker BA
    Haematologica; 2017 Sep; 102(9):1617-1625. PubMed ID: 28550183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative analysis of CKS1B mRNA expression and copy number gain in patients with plasma cell disorders.
    Stella F; Pedrazzini E; Baialardo E; Fantl DB; Schutz N; Slavutsky I
    Blood Cells Mol Dis; 2014 Sep; 53(3):110-7. PubMed ID: 24973170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low serum miR-19a expression as a novel poor prognostic indicator in multiple myeloma.
    Hao M; Zang M; Wendlandt E; Xu Y; An G; Gong D; Li F; Qi F; Zhang Y; Yang Y; Zhan F; Qiu L
    Int J Cancer; 2015 Apr; 136(8):1835-44. PubMed ID: 25220540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical analysis of NOTCH1 and JAGGED1 expression in multiple myeloma and monoclonal gammopathy of undetermined significance.
    Skrtić A; Korać P; Krišto DR; Ajduković Stojisavljević R; Ivanković D; Dominis M
    Hum Pathol; 2010 Dec; 41(12):1702-10. PubMed ID: 20800871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and significance of miR-21 in multiple myeloma patients.
    Wang JH; Zhou WW; Liu BX; Man DL; Yang ZD; Liu FR; Shang H
    Genet Mol Res; 2016 Jan; 15(1):. PubMed ID: 26909911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative polymerase Chain reaction profiling of microRNAs in peripheral lymph-monocytes from MGUS subjects.
    Avenoso A; Campo S; Scuruchi M; Mania M; Innao V; D'Ascola A; Mandraffino G; Allegra AG; Musolino C; Allegra A
    Pathol Res Pract; 2021 Feb; 218():153317. PubMed ID: 33360970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis.
    Pichiorri F; Suh SS; Ladetto M; Kuehl M; Palumbo T; Drandi D; Taccioli C; Zanesi N; Alder H; Hagan JP; Munker R; Volinia S; Boccadoro M; Garzon R; Palumbo A; Aqeilan RI; Croce CM
    Proc Natl Acad Sci U S A; 2008 Sep; 105(35):12885-90. PubMed ID: 18728182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic role of circulating exosomal miRNAs in multiple myeloma.
    Manier S; Liu CJ; Avet-Loiseau H; Park J; Shi J; Campigotto F; Salem KZ; Huynh D; Glavey SV; Rivotto B; Sacco A; Roccaro AM; Bouyssou J; Minvielle S; Moreau P; Facon T; Leleu X; Weller E; Trippa L; Ghobrial IM
    Blood; 2017 Apr; 129(17):2429-2436. PubMed ID: 28213378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.